Malaria Drug Improves Efficacy of Glioblastoma Treatment


“A treatment regimen that included the inexpensive anti-malaria drug chloroquine dramatically improved survival and quality of life for three patients with glioblastoma, according to researchers from University of Colorado Cancer Center.

“Two of the patients maintained response to treatment for more than 2 years.

” ‘We were excited that the three patients who tried the combination all had some clinical benefit,’ Jean Mulcahy Levy, MD, investigator at University of Colorado Cancer Center and pediatric oncologist at Children’s Hospital Colorado, told HemOnc Today. ‘This supports examining this combination in a broader clinical trial and assessing its efficacy in a larger patient population.’ ”

Go to full article.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our ASK Cancer Commons service.